Press "esc" to clear
Go to Advanced Search

Showing results

110 of 1075
Embargo will expire:
17-Aug-2018 11:00 AM EDT
Released to reporters:
14-Aug-2018 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 17-Aug-2018 11:00 AM EDT

buffalo_healthcare_exploration_smaller_image.jpg

Article ID: 698973

Local High School Students Explore Diverse Healthcare Field at Roswell Park

Roswell Park Comprehensive Cancer Center

y-two local high school students participated in a unique career development program at Roswell Park Comprehensive Cancer Center this summer. The Buffalo Healthcare Exploration (BHE) program

Released:
14-Aug-2018 1:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Education

Article ID: 698966

Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future

Memorial Sloan Kettering Cancer Center

Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.

Released:
14-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698933

Seattle Cancer Care Alliance again ranked in the Top 10 in the nation for adult cancer care

Seattle Cancer Care Alliance

Seattle Cancer Care Alliance (SCCA) / University of Washington Medical Center (UWMC) is ranked among the best in the nation for adult cancer care by U.S. News & World Report for 2018-2019.

Released:
14-Aug-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
AshishRai.jpg
  • Embargo expired:
    14-Aug-2018 9:25 AM EDT

Article ID: 698889

Better Doctor/Patient Communication Means Better Outcomes in Cancer Care, According to a Report in JNCCN

National Comprehensive Cancer Network® (NCCN®)

Study from the American Cancer Society, published in JNCCN--Journal of the National Comprehensive Cancer Network, found cancer patients who were more satisfied with the communication they received, had better health results at lower costs

Released:
13-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
knudsen-square.jpg

Article ID: 698885

AACI Members Choose Knudsen President-Elect, Four Added to Board of Directors

Association of American Cancer Institutes (AACI)

The members of the Association of American Cancer Institutes (AACI) have elected Karen E. Knudsen, PhD, as vice president/president-elect of AACI’s board of directors. In addition to Dr. Knudsen, four leaders of AACI member cancer centers will join the board at the AACI/CCAF Annual Meeting on September 30.

Released:
13-Aug-2018 12:05 PM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
Cole_EmbraceKidsFamily_LabDV0818.jpg

Article ID: 698820

$1M Commitment from Embrace Kids Foundation Supports Recruitment of Pediatric Cancer Research Faculty at Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey

Rutgers Cancer Institute of New Jersey now has additional resources in the fight against pediatric cancers and blood disorders, thanks to a $1 million commitment from Embrace Kids Foundation that will support the recruitment of pediatric cancer research faculty.

Released:
13-Aug-2018 10:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698802

MD Anderson and Accelerator Life Science Partners Launch Magnolia Neurosciences to Speed Development of Neuroprotective Therapies

University of Texas M. D. Anderson Cancer Center

The University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, today announced the launch of Magnolia Neurosciences Corporation, a company developing a new class of neuroprotective medicines, with $31 million in Series A funding. The company will develop novel therapeutics based on discoveries made by researchers in MD Anderson’s Therapeutics Discovery division, including the Institute for Applied Cancer Science (IACS) and the Neurodegeneration Consortium (NDC).

Released:
13-Aug-2018 6:00 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Article ID: 698772

New Study Views Cancer Treatment as a Game to Find Strategies That Improve Patient Outcomes

Moffitt Cancer Center

TAMPA, Fla. – Game theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve outcomes in patients with metastatic cancer, according to a new article published online today by JAMA Oncology. The study, which is authored by a mathematician, an evolutionary biologist and clinical physicians from the Moffitt Cancer Center and Maastricht University, challenges the decades old standard of treatment for metastatic cancers in which drugs are typically administered continuously at the maximum-tolerated dose (MTD) until the tumor progresses.

Released:
9-Aug-2018 11:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment
  • Embargo expired:
    9-Aug-2018 9:00 AM EDT

Article ID: 698468

NCCN Publishes First-Ever U.S. Guidelines for Rare Cancers Associated with Pregnancy

National Comprehensive Cancer Network® (NCCN®)

New NCCN Guidelines for gestational trophoblastic neoplasia created to ensure pregnant women with cancer receive life-saving treatment while preserving fertility

Released:
2-Aug-2018 10:05 AM EDT
EXPERT AVAILABLE
Open in New Tab
Add to Favorites
Comment

Showing results

110 of 1075





Chat now!